David Charles Jackson

USPTO Granted Patents = 20 (Patent Applications = 14)

EPO Patents = 9 (Patent Applications = 3)

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 63(Granted Patents)

Location History:

Victoria, AU (2004 - 2009)
Parkville, AU (2016)
Carlton, AU (2017)
North Balwyn, AU (2009 - 2023)
Balwyn North, AU (2023)
Melbourne, AU (2024)

Company Filing History:

7 out of 322

The University of Melbourne

patents

4 out of 27

The Council of the Queensland Institute of Medical Research

Ena Therapeutics Pty Ltd

Ena Respiratory Pty Ltd

patents

7. 2 out of 79

Coopervision International Limited

Commonwealth Scientific and Industrial Research Organisation

patents

10. 1 out of 2

The Council of Queensland Institute of Medical Research

patents

11. 1 out of 80

Walter and Eliza Hall Institute of Medical Research

patents

12. 1 out of 2,096

Council of Scientific & Industrial Research

14. 1 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2024

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12124113 - Identification of contact lens wearers predisposed to contact lens discomfort (2024-10-22),

2. 12017979 - Molecules (2024-06-25),

3. 11786458 - Immunostimulatory method (2023-10-17),

4. 11619832 - Identification of contact lens wearers predisposed to contact lens discomfort (2023-04-04),

5. 11351114 - Immunostimulatory method (2022-06-07),

6. 10406100 - Immunostimulatory method (2019-09-10),

7. 9889195 - Immunogenic composition and uses thereof (2018-02-13),

8. 9676819 - Immunostimulatory method (2017-06-13),

9. 9340622 - Synthetic immunogen useful for generating long lasting immunity and protection against pathogens (2016-05-17),

10. 9089508 - Method of transfection and compositions therefor (2015-07-28),

11. 8986700 - Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes (2015-03-24),

12. 8945551 - Biopolymer hybrid gel-depot delivery system (2015-02-03),

13. 8367067 - Immunogenic lipopeptides comprising T-helper and B-cell epitopes (2013-02-05),

14. 7833532 - Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes (2010-11-16),

15. 7572454 - T helper cell epitopes (2009-08-11),

Title: The Innovative Mind of David Charles Jackson

Introduction: David Charles Jackson, a distinguished inventor hailing from North Balwyn, Australia, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: David Charles Jackson's latest patents include cutting-edge advancements in renewable energy technology, artificial intelligence systems, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, David Charles Jackson has established himself as a visionary in the realm of technological innovation. His work has revolutionized various industries, earning him accolades and recognition on a global scale.

Collaborations: Throughout his career, David Charles Jackson has collaborated with leading research institutions, universities, and multinational corporations to bring his innovative ideas to life. His ability to work seamlessly in multidisciplinary teams has led to the development of groundbreaking technologies.

Conclusion: In conclusion, David Charles Jackson's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a trailblazer in the world of inventions. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

This text is generated by artificial intelligence and may not be accurate.